Pearson claims
This article was originally published in The Tan Sheet
Executive Summary
FDA will make a final determination by Oct. 10 on the four proposed health claims, CFSAN says in a July 14 update on its 2000 program priorities. In light of the impending deadline, the Pearson plaintiffs say they are withdrawing their appeal of a D.C. federal judge's decision denying their motion to force the agency to allow immediate use of the four claims with appropriate disclaimers (1"The Tan Sheet" June 5, p. 14). CFSAN also announces a Nov. 24 deadline for determining whether health claims with qualifying disclaimers may be made for vitamin E/heart disease and vitamin B/vascular disease. The agency previously denied the two claims, finding they did not meet its significant scientific agreement standard (2"The Tan Sheet" Jan. 24, p. 10)